Market Overview:
The global vial and prefilled syringe market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for vials and prefilled syringes from the pharmaceutical and biotechnology industries, rising prevalence of chronic diseases, and technological advancements in vial and prefilled syringe manufacturing processes. The global vial and prefilled syringe market is segmented on the basis of type into glass vials and pre-filled syringes, polymer vials and pre-filled syringes, elastomeric closures (ECs), aluminum closures (ACs), plastic caps (PCs), rubber stoppers (RSs), Luer locks/Luer connectors (LL/LCs) etc., In terms of application, the market is segmented into antithrombotics, vaccines, autoimmune diseases drugs anti-inflammatory drugs etc.
Product Definition:
A Vial is a container made of glass or plastic, typically used to store liquids.
A Prefilled Syringe is a prefilled syringe with a needle attached. It contains one dose of medicine and is ready for use when you remove the cap.
Glass Vial and Prefilled Syringe:
Glass vial and pre-filled syringe are used to contain a precise amount of liquid or solid pharmaceutical products. They are made up of thick glass, which is highly resistant to physical impact, and has a capacity that can resist the pressure inside the container. The vials come in different sizes depending upon the dose; they have capacities ranging from 2 ml to 100 ml.
Polymer Vial and Prefilled Syringe:
Polymer vial and pre-filled syringe are used for the packaging of liquid products. They can be used with most liquids, however some solvents such as ethanol, acetone, and water-based paints/lacquers may not be able to be stored in a polymer vial due to their high vapor pressure.
Application Insights:
Based on the application, the global market is segmented into antithrombotics, vaccines, autoimmune diseases, anti-inflammatory drugs and other. In 2017, antithrombotics held the largest share in terms of revenue as well as volume. Increasing incidence of thrombosis has become a major concern for healthcare professionals and patients across the globe. As per WHO estimates published in 2016, around 6 million deaths occur every year due to stroke globally. Thus growing demand for vial and prefilled syringes among pharmaceutical companies that manufacture anticoagulants is expected to boost segment growth during forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of major players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors contributing to its growth. In addition, growing demand for vaccines and autoantibodies is expected to drive this region’s market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with improving healthcare infrastructure in emerging countries such as China and India. Moreover, an increase in awareness about blood donation programs will also boost product demand over the next eight years. ‰˜˜˜˜˜™‰™‰ªœ© 2018 Bio-Rad Laboratories Ltd.
Growth Factors:
- Increasing demand for injectable drugs: The global market for injectable drugs is expected to grow at a CAGR of 6.5% from 2016 to 2021. This growth can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for biologics and biosimilars. Injectable drugs are preferred over oral medications as they provide rapid relief from symptoms and are easy to administer.
- Technological advancements in prefilled syringes: The prefilled syringe market is witnessing significant technological advancements with the advent of novel features such as smart needles, safety shields, and automatic needle retraction systems. These features are helping manufacturers cater to the needs of different patient segments such as pediatric patients and those suffering from chronic diseases.
- Growing number of self-injection users: A large number of people across the globe are increasingly using self-injection devices for various medical purposes such as diabetes management, fertility treatment, etc.). This is driving the demand for prefilled syringes globally. Additionally, growing awareness about hygiene among patients is also contributing to the growth of this market segment..
Scope Of The Report
Report Attributes
Report Details
Report Title
Vial and Prefilled Syringe Market Research Report
By Type
Glass Vial and Prefilled Syringe, Polymer Vial and Prefilled Syringe
By Application
Antithrombotics, Vaccines, Autoimmune Diseases, Anti-inflammatory Drugs, Other
By Companies
BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP), Vetter (DE), Unilife Corporation (US), Taisei Kako (JP), Roselabs Group (IN), ARTE CORPORATION (JP), Weigao Group Medical Polymer (CN), Zibo Minkang Pharmaceutical (CN), Shandong Pharmaceutical Glass (CN)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Vial and Prefilled Syringe Market Report Segments:
The global Vial and Prefilled Syringe market is segmented on the basis of:
Types
Glass Vial and Prefilled Syringe, Polymer Vial and Prefilled Syringe
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antithrombotics, Vaccines, Autoimmune Diseases, Anti-inflammatory Drugs, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD (US)
- Gerresheimer (DE)
- Nipro Corporation (JP)
- Schott forma vitrum (DE)
- Ompi (IT)
- Baxter BioPharma Solution (US)
- ROVI CM (ES)
- Terumo (JP)
- Vetter (DE)
- Unilife Corporation (US)
- Taisei Kako (JP)
- Roselabs Group (IN)
- ARTE CORPORATION (JP)
- Weigao Group Medical Polymer (CN)
- Zibo Minkang Pharmaceutical (CN)
- Shandong Pharmaceutical Glass (CN)
Highlights of The Vial and Prefilled Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glass Vial and Prefilled Syringe
- Polymer Vial and Prefilled Syringe
- By Application:
- Antithrombotics
- Vaccines
- Autoimmune Diseases
- Anti-inflammatory Drugs
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vial and Prefilled Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A vial is a sealed container that can hold a liquid or gas. A prefilled syringe is an injection device that contains the medication ready to be injected.
Some of the major players in the vial and prefilled syringe market are BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP), Vetter (DE), Unilife Corporation (US), Taisei Kako (JP), Roselabs Group (IN), ARTE CORPORATION (JP), Weigao Group Medical Polymer (CN), Zibo Minkang Pharmaceutical (CN), Shandong Pharmaceutical Glass (CN).
The vial and prefilled syringe market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vial and Prefilled Syringe Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vial and Prefilled Syringe Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vial and Prefilled Syringe Market - Supply Chain
4.5. Global Vial and Prefilled Syringe Market Forecast
4.5.1. Vial and Prefilled Syringe Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vial and Prefilled Syringe Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vial and Prefilled Syringe Market Absolute $ Opportunity
5. Global Vial and Prefilled Syringe Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vial and Prefilled Syringe Market Size and Volume Forecast by Type
5.3.1. Glass Vial and Prefilled Syringe
5.3.2. Polymer Vial and Prefilled Syringe
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vial and Prefilled Syringe Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vial and Prefilled Syringe Market Size and Volume Forecast by Application
6.3.1. Antithrombotics
6.3.2. Vaccines
6.3.3. Autoimmune Diseases
6.3.4. Anti-inflammatory Drugs
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vial and Prefilled Syringe Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vial and Prefilled Syringe Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vial and Prefilled Syringe Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vial and Prefilled Syringe Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vial and Prefilled Syringe Demand Share Forecast, 2019-2029
9. North America Vial and Prefilled Syringe Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vial and Prefilled Syringe Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vial and Prefilled Syringe Market Size and Volume Forecast by Application
9.4.1. Antithrombotics
9.4.2. Vaccines
9.4.3. Autoimmune Diseases
9.4.4. Anti-inflammatory Drugs
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vial and Prefilled Syringe Market Size and Volume Forecast by Type
9.7.1. Glass Vial and Prefilled Syringe
9.7.2. Polymer Vial and Prefilled Syringe
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vial and Prefilled Syringe Demand Share Forecast, 2019-2029
10. Latin America Vial and Prefilled Syringe Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vial and Prefilled Syringe Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vial and Prefilled Syringe Market Size and Volume Forecast by Application
10.4.1. Antithrombotics
10.4.2. Vaccines
10.4.3. Autoimmune Diseases
10.4.4. Anti-inflammatory Drugs
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vial and Prefilled Syringe Market Size and Volume Forecast by Type
10.7.1. Glass Vial and Prefilled Syringe
10.7.2. Polymer Vial and Prefilled Syringe
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vial and Prefilled Syringe Demand Share Forecast, 2019-2029
11. Europe Vial and Prefilled Syringe Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vial and Prefilled Syringe Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vial and Prefilled Syringe Market Size and Volume Forecast by Application
11.4.1. Antithrombotics
11.4.2. Vaccines
11.4.3. Autoimmune Diseases
11.4.4. Anti-inflammatory Drugs
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vial and Prefilled Syringe Market Size and Volume Forecast by Type
11.7.1. Glass Vial and Prefilled Syringe
11.7.2. Polymer Vial and Prefilled Syringe
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vial and Prefilled Syringe Demand Share, 2019-2029
12. Asia Pacific Vial and Prefilled Syringe Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vial and Prefilled Syringe Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vial and Prefilled Syringe Market Size and Volume Forecast by Application
12.4.1. Antithrombotics
12.4.2. Vaccines
12.4.3. Autoimmune Diseases
12.4.4. Anti-inflammatory Drugs
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vial and Prefilled Syringe Market Size and Volume Forecast by Type
12.7.1. Glass Vial and Prefilled Syringe
12.7.2. Polymer Vial and Prefilled Syringe
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vial and Prefilled Syringe Demand Share, 2019-2029
13. Middle East & Africa Vial and Prefilled Syringe Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vial and Prefilled Syringe Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vial and Prefilled Syringe Market Size and Volume Forecast by Application
13.4.1. Antithrombotics
13.4.2. Vaccines
13.4.3. Autoimmune Diseases
13.4.4. Anti-inflammatory Drugs
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vial and Prefilled Syringe Market Size and Volume Forecast by Type
13.7.1. Glass Vial and Prefilled Syringe
13.7.2. Polymer Vial and Prefilled Syringe
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vial and Prefilled Syringe Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Vial and Prefilled Syringe Market: Market Share Analysis
14.2. Vial and Prefilled Syringe Distributors and Customers
14.3. Vial and Prefilled Syringe Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Gerresheimer (DE)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nipro Corporation (JP)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Schott forma vitrum (DE)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ompi (IT)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Baxter BioPharma Solution (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ROVI CM (ES)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Terumo (JP)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vetter (DE)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Unilife Corporation (US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Taisei Kako (JP)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Roselabs Group (IN)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. ARTE CORPORATION (JP)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Weigao Group Medical Polymer (CN)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Zibo Minkang Pharmaceutical (CN)
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Shandong Pharmaceutical Glass (CN)
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
